CBD might cause breast cancer cells to be less aggressive by mesenchymal reversion to an epithelial phenotype via IL-1β/IL-1R/β-catenin, E-cadherin/β-catenin complex relocalization, and other protein markers of malignancy [19]. Here, IL1R1 is linked to breast carcinoma.